PR & Marketing Industry Today
Intragastric Balloons Market to Reach USD 364.6 Million by 2036, Driven by Rising Obesity and Advances in Minimally Invasive Weight-Loss Technologies
The global intragastric balloons market is poised for significant expansion, with market value projected to increase from USD 86.8 million in 2025 to USD 364.6 million by 2036, registering a CAGR of 13.9% from 2026 to 2036. Rising obesity rates worldwide, growing awareness of non-surgical weight-loss treatments, and continuous innovation in swallowable and adjustable balloon technologies are expected to remain major contributors to market growth.
Market Overview: Intragastric balloons are minimally invasive medical devices designed to support weight loss by occupying space within the stomach and promoting an earlier feeling of fullness. The treatment is generally temporary and can provide an alternative to more invasive bariatric surgical procedures for eligible patients.
Increasing healthcare expenditure, expanding bariatric infrastructure, and growing patient preference for reversible and less invasive obesity-management solutions are creating favorable conditions for market expansion. Hospitals, ambulatory surgical centers, and specialty clinics are increasingly incorporating endoscopic weight-management procedures into broader obesity treatment programs.
Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26006
Key Drivers of Market Growth
The growing global prevalence of overweight and obesity represents one of the strongest growth drivers for the market. Changing lifestyles, urbanization, sedentary behavior, and increased consumption of high-calorie processed foods have contributed to the rising burden of obesity and related conditions, including type 2 diabetes, cardiovascular disease, hypertension, and sleep apnea.
At the same time, technological advancements are transforming the intragastric balloon landscape. Swallowable balloon systems can reduce or eliminate the need for endoscopic placement and anesthesia in suitable patients, while adjustable balloons enable physicians to modify balloon volume according to patient tolerance and treatment response.
Improvements in balloon materials, valve systems, durability, and safety are also helping reduce concerns related to deflation, migration, and removal. Increasing clinical evidence and regulatory approvals are further supporting physician and patient confidence in these technologies.
Key Players and Industry Leaders
The competitive landscape includes several established and emerging participants. Prominent companies operating in the market include Boston Scientific Corporation, Apollo Endosurgery, Medtimo, Inc., Spatz FGIA Inc., GI Alliance, Medispar NV, Helioscopie, Laboratoire Endalis, Silimed, MICRO-TECH (Nanjing) Co., Ltd., Bariatric Solutions GmbH, and OxiGênios, among others.
Recent industry developments highlight the rapid pace of innovation. In February 2026, Allurion Technologies announced FDA approval of the premarket approval application for its Allurion Gastric Balloon System featuring the Allurion Smart Capsule. The system is designed to be swallowed during an office visit and aims to eliminate the need for surgery, endoscopy, or anesthesia for placement.
In February 2024, Spatz Medical announced the commercialization of the Spatz3 Adjustable Gastric Balloon in the U.S., following its adoption across more than 60 markets.
Visit our report to explore critical insights and analysis - https://www.transparencymarketresearch.com/intragastric-balloons-market.html
Key Trends for the Future
The market is increasingly moving toward patient-friendly, personalized, and less invasive treatment approaches. Swallowable balloons, adjustable systems, improved materials, and digitally supported obesity-management programs are expected to shape future demand.
Another important trend is the integration of balloon therapy with nutritional counseling, lifestyle modification, remote monitoring, and telemedicine. Such comprehensive programs can help patients maintain healthier behaviors after treatment and potentially address concerns surrounding weight regain following balloon removal.
New Opportunities and Challenges
Medical tourism presents an emerging opportunity, particularly in countries such as India, Thailand, Turkey, Mexico, and the United Arab Emirates. These destinations can offer advanced healthcare infrastructure and experienced specialists at comparatively lower treatment costs, making them attractive to international patients seeking obesity treatment.
However, challenges remain. Treatment costs, limited reimbursement in some countries, possible adverse effects such as nausea and stomach discomfort, and concerns regarding balloon displacement can restrict adoption. The temporary nature of treatment and potential weight regain after removal may also influence long-term patient acceptance.
Market Trends & Innovations
Innovation is focused on improving comfort, treatment effectiveness, procedural simplicity, and safety. Single-balloon systems currently hold a leading position because of their established clinical evidence, ease of use, and broad availability.
The single balloon segment accounted for approximately 54.2% of market revenue in 2025. Continued improvements in balloon design and durability are expected to help this segment retain a substantial share during the forecast period.
Future Outlook
North America led the global intragastric balloons market in 2025, accounting for approximately 41.2% of total revenue. The region benefits from high obesity prevalence, advanced healthcare infrastructure, specialized bariatric centers, experienced gastroenterologists, and increasing awareness of non-surgical weight-loss solutions.
Looking ahead, the combination of rising obesity prevalence, technological innovation, expanding clinical adoption, and increasing demand for minimally invasive procedures is expected to support strong market growth through 2036.
Buy this Premium Research Report to explore detailed market trends - https://www.transparencymarketresearch.com/checkout.php?rep_id=26006<ype=S
Market Segmentation
The intragastric balloons market can be segmented by:
- Product Type: Single Balloon, Dual Balloon, Triple Balloon
- Filling Material: Saline-Filled Balloons, Gas-Filled Balloons
- Duration of Implantation: Up to 6 Months, 6–12 Months, More than 12 Months
- Patient Type: Adults, Adolescents
- End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others
- Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Important FAQs
How large was the intragastric balloons market in 2025?
The global market was valued at USD 86.8 million in 2025.
What is the projected market size by 2036?
The market is projected to reach USD 364.6 million by 2036.
What is the expected CAGR?
The market is expected to expand at a 13.9% CAGR from 2026 to 2036.
What are the major growth drivers?
Rising obesity prevalence and technological advancements in swallowable, adjustable, and next-generation intragastric balloon systems are key drivers.
Which region dominated the market in 2025?
North America led the market with approximately 41.2% revenue share.
Which product type held the largest share?
The single balloon segment held the largest share, accounting for approximately 54.2% of revenue in 2025.
Who are the major market players?
Key participants include Boston Scientific Corporation, Apollo Endosurgery, Medtimo, Spatz FGIA, GI Alliance, Medispar, Helioscopie, Laboratoire Endalis, Silimed, MICRO-TECH, Bariatric Solutions, and OxiGênios.
Explore Latest Research Reports by Transparency Market Research
Pulmonary Drug Delivery Devices Market
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!

